Page 106 - ITPS-8-2
P. 106
INNOSC Theranostics and
Pharmacological Sciences Fungal markers in intracranial fungal infections
only the importance of fungal markers in early diagnosis paper has been uploaded to ResearchGate (doi: 10.13140/
could be assessed and not treatment efficacy. RG.2.2.33961.61287).
4. Conclusion References
Given the limited data on fungal infections in Pakistan 1. Murthy JMK, Sundaram C. Fungal infections of the central
and the lack of IFI-centered studies, the epidemiology is nervous system. Handb Clin Neurol. 2013;121:1383-1401.
largely unknown. Consequently, the diagnostic approach is doi: 10.1016/b978-0-7020-4088-7.00095-x
suboptimal. Although imaging studies and biopsy are the 2. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions
gold standards for IFI diagnosis, the gap in noninvasive of invasive fungal disease from the European organization for
modalities must be assessed. Our findings highlight the research and treatment of cancer/invasive fungal infections
importance of serological fungal biomarkers (GM and cooperative group and the national institute of allergy and
BDG) and CSF analysis as adjuncts to the gold standard infectious diseases mycoses study group (EORTC/MSG)
diagnostic tools. Furthermore, we propose the inclusion consensus group. Clin Infect Dis. 2008;46(12):1813-1821.
of fungal biomarker assays using CSF specimens in future doi: 10.1086/588660
diagnostic protocols.
3. Chen M, Chen C, Yang Q, Zhan R. Candida meningitis in
Acknowledgments neurosurgical patients: A single-institute study of nine cases
over 7 years. Epidemiol Infect. 2020;148:e148.
None.
doi: 10.1017/s0950268820001144
Funding 4. Krishnan S, Manavathu EK, Chandrasekar PH. Aspergillus
None. flavus: An emerging non-fumigatus Aspergillus species of
significance. Mycoses. 2009;52(3):206-222.
Conflict of interest doi: 10.1111/j.1439-0507.2008.01642.x
The authors declare that they have no competing interests. 5. Rasoolinejad M, Hajiabdolbaghi M, Manshadi SAD,
Ardalan FA, Moradnejad P, Alijani N. Cerebral aspergillosis
Author contributions in an immunocompetent patient: A case report. Arch
Conceptualization: Suneel Kumar, Zuhaa Rehman Neurosci. 2015;3(2):e31710.
Formal analysis: Zuhaa Rehman doi: 10.5812/archneurosci.31710
Investigation: Suneel Kumar, Naeemullah Bullo, Munir Afzal 6. Muñoz P, Guinea J, Bouza E. Update on invasive
Methodology: Zuhaa Rehman, Suneel Kumar aspergillosis: Clinical and diagnostic aspects. Clin Microbiol
Writing–original draft: Zuhaa Rehman, Anabia Akhlaq, Infect. 2006;12:24-39.
Taha bin Ajaz Khan doi: 10.1111/j.1469-0691.2006.01603.x
Writing–review & editing: Zuhaa Rehman, Suneel Kumar
7. Shamim MS, Siddiqui AA, Enam SA, Shah AA, Jooma R,
Ethics approval and consent to participate Anwar S. Craniocerebral aspergillosis in immunocompetent
hosts: Surgical perspective. Neurol India. 2007;55(3):274-281.
This study was approved by the Institutional Review Board
Committee of JPMC under the IRB number NO.F.2- doi: 10.4103/0028-3886.35689
81/2023-GENL/92/JPMC. 8. Haddad E, Fekkar A, Bonnin S, et al. Cerebral vasculitis
due to Aspergillus spp. in immunocompromised patients:
Consent for publication Literature review. Int J Infect Dis. 2022;122:244-251.
The retrospective case series was conducted using doi: 10.1016/j.ijid.2022.05.056
deidentified data from the department registry. Hence, 9. Santana-Ramírez A, Esparza-Gutiérrez SV,
consent for publication was not required. Avila-Rodríguez P, Jiménez-Gómez J.E, Vélez-Gómez E,
Bañuelos-Gallo D. Aspergillosis of the central nervous system
Availability of data in a previously healthy patient that simulated Creutzfeldt-
The data can be shared on request. Jakob disease. Surg Neurol Int. 2016;7(40):S940-S946.
doi: 10.4103/2152-7806.195230
Further disclosure
10. Lamoth, F. Galactomannan and 1,3-β-d-glucan testing
Part of or the entire set of findings has been presented in for the diagnosis of invasive aspergillosis. J Fungi (Basel).
a conference – 9 Annual Neuroscience Conference. The 2016;2(3):22.
th
Volume 8 Issue 2 (2025) 100 doi: 10.36922/itps.4528

